Evidence map›Paper›PMID 37348738›Full record

ArticleMolecular metabolism2023

Free fatty acid receptor 1 stimulates cAMP production and gut hormone secretion through Gq-mediated activation of adenylate cyclase 2.

Jacob Emil Petersen, Maria Hauge Pedersen, Oksana Dmytriyeva, Emilie Nellemose, Tulika Arora, Maja Storm Engelstoft, Wesley B Asher, Jonathan A Javitch, Thue W Schwartz, Mette Trauelsen

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Dietary tributyrin supplementation in Parkinson's disease: An open-label target engagement study.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Cellular mechanisms of incretin hormone secretion.Journal of molecular endocrinology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jacob Emil PetersenNNF Center for Basic Metabolic Research, Program for Nutrient and Metabolite Sensing and Signaling, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Maria Hauge PedersenNNF Center for Basic Metabolic Research, Program for Nutrient and Metabolite Sensing and Signaling, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark; Departments of Psychiatry & Molecular Pharmacology and Therapeutics, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.
Oksana DmytriyevaNNF Center for Basic Metabolic Research, Program for Nutrient and Metabolite Sensing and Signaling, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Emilie NellemoseNNF Center for Basic Metabolic Research, Program for Nutrient and Metabolite Sensing and Signaling, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Tulika AroraNNF Center for Basic Metabolic Research, Program for Nutrient and Metabolite Sensing and Signaling, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Maja Storm EngelstoftKallyope, New York, NY, USA.
Wesley B AsherDepartments of Psychiatry & Molecular Pharmacology and Therapeutics, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.
Jonathan A JavitchDepartments of Psychiatry & Molecular Pharmacology and Therapeutics, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.
Thue W SchwartzNNF Center for Basic Metabolic Research, Program for Nutrient and Metabolite Sensing and Signaling, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Mette TrauelsenNNF Center for Basic Metabolic Research, Program for Nutrient and Metabolite Sensing and Signaling, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address: trauelsen@sund.ku.dk.
University of Copenhagen · DKNew York Psychoanalytic Society and Institute · USKallyope (United States) · US

Funding

Structure of the Dopamine D2-Like Receptor Binding SitesR01MH054137 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI JAVITCH, JONATHAN A · 1995 to 2025
$12.0M
NIMH NIH HHS R01 MH054137
6 · The paper itself

Abstract

objectiveFree fatty acid receptor 1 (FFAR1) is highly expressed in enteroendocrine cells of the small intestine and pancreatic beta cells, where FFAR1 agonists function as GLP-1 and insulin secretagogues, respectively. Most efficacious are so-called second-generation synthetic agonists such as AM5262, which, in contrast to endogenous long-chain fatty acids are able to signal through both IP METHODS AND

resultsWhen stimulated with AM5262, we observe that FFAR1 can activate the majority of the Gα proteins, except - surprisingly - members of the Gs family. AM5262-induced FFAR1-mediated transcriptional activation through cAMP response element (CREB) was blocked by the specific Gq inhibitor, YM253890. Furthermore, in Gq-deficient cells no CREB signal was observed unless Gq or G11 was reintroduced by transfection. By qPCR we determined that adenylate cyclase 2 (Adcy2) was highly expressed and enriched relative to the nine other Adcys in pro-glucagon expressing enteroendocrine cells. Co-transfection with ADCY2 increased the FFAR1-induced cAMP response 4-5-fold in WT HEK293 cells, an effect fully inhibited by YM253890. Moreover, co-transfection with ADCY2 had no effect in Gq-deficient cells without reintroduction of either Gq or G11. Importantly, although both AM5262/FFAR1 and isoproterenol/β2 adrenergic receptor (β2AR) induced cAMP production was lost in Gs-deficient cells, only the β2AR response was rescued by Gs transfection, whereas co-transfection with ADCY2 was required to rescue the FFAR1 cAMP response. In situ hybridization demonstrated a high degree of co-expression of ADCY2 and FFAR1 in enteroendocrine cells throughout the intestine. Finally, in the enteroendocrine STC-1 and GLUTag cell lines AM5262-induced cAMP accumulation and GLP-1 secretion were both blocked by YM253890.

conclusionsOur results show that Gq signaling is responsible not only for the IP

Indexed as

Adenylyl CyclasesFatty Acids, NonesterifiedGlucagon-Like Peptide 1HEK293 CellsHumansReceptors, G-Protein-CoupledAdenylyl CyclasesFatty Acids, NonesterifiedGlucagon-Like Peptide 1Receptors, G-Protein-CoupledADCY2Adenylate cyclase 2FFAR1GLP-1GPR40Gq

Identifiers

PMID37348738
PMCPMC10394103
OpenAlexW4381325572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.